Linking the p53 tumour suppressor pathway to somatic cell reprogramming

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673

Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors

Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221

Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells

Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., et al. (2007) · Science · doi:10.1126/science.1151526 · Cited by 10,310

In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2

Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661

Generation of germline-competent induced pluripotent stem cells

Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,438

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

Toshiyuki, M., & Reed, J. C. (1995) · Cell · doi:10.1016/0092-8674(95)90412-3 · Cited by 4,063

Reprogramming of human somatic cells to pluripotency with defined factors

Park, I.-H., Zhao, R., West, J. A., Yabuuchi, A., Huo, H., Ince, T. A., Lerou, P. H., Lensch, M. W., & Daley, G. Q. (2008) · Nature · doi:10.1038/nature06534 · Cited by 2,436

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380

Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins

Kim, D., Kim, C.-H., Moon, J.-I., Chung, Y.-G., Chang, M.-Y., Han, B.-S., Ko, S., Yang, E., Cha, K. Y., Lanza, R., et al. (2009) · Cell stem cell · doi:10.1016/j.stem.2009.05.005 · Cited by 1,814

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626

Progress and Future Challenges of Human Induced Pluripotents Stem Cell in Regenerative Medicine

Meiliana, A., & Wijaya, A. (2011) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v3i2.138 · Cited by 2

Role of microRNA in induced pluripotent stem cell

Chun-Sheng, W. A. N. G., ZHANG, Z.-R., Piao, S., & Tie-zhu, A. (2012) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2012.01545 · Cited by 2

The effect of microRNAs on the regulatory network of pluripotency in embryonic stem cells

Bai, Y., Li, L., Wei, H., Zhu, C., & Zhang, S. (2013) · Hereditas (Beijing) · doi:10.3724/sp.j.1005.2013.01153 · Cited by 2

Transformation to Inducible Pluripotent Stem Cells

Kodo, K., Ong, S., & Wu, J. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801888-0.00020-5 · Cited by 3

Induced Pluripotency: Generation of iPS Cells from Mouse Embryonic Fibroblasts

Li, H., Strati, K., Domínguez, V., Martín, J., Blasco, M. A., Serrano, M., & Ortega, S. (2011) · Springer protocols handbooks/Springer protocols · doi:10.1007/978-3-642-20792-1_20 · Cited by 2

Basic fibroblast growth factor is critical to reprogramming buffalo ( Bubalus bubalis ) primordial germ cells into embryonic germ stem cell-like cells

Wang, C., Deng, Y., Chen, F., Zhu, P., Wei, J., Luo, C., Lu, F., Yang, S., & Shi, D. (2016) · Theriogenology · doi:10.1016/j.theriogenology.2016.12.035 · Cited by 2

Pluripoteny and Cancer, Two Sides of The Same Coin?

(2015) · Human Genetics & Embryology · doi:10.4172/2161-0436.1000e110 · Cited by 2

Cellular Reprogramming and Aging

Pereira, S. N., & de Jesus, B. B. (2020) · Learning materials in biosciences · doi:10.1007/978-3-030-43939-2_5 · Cited by 2

Induced Pluripotent Stem Cells

Okita, K., & Yamanaka, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-381422-7.10013-6 · Cited by 2

Cartilage Regeneration Using Induced Pluripotent Stem Cell Technologies

Tsumaki, N. (2014) · Mechanical engineering series · doi:10.1007/978-3-319-13266-2_6 · Cited by 2

Senescent-Derived Pluripotent Stem Cells Are Able to Redifferentiate into Fully Rejuvenated Cells

Milhavet, O., & Lemaı̂tre, J.-M. (2013) · Springer eBooks · doi:10.1007/978-94-007-7726-2_25 · Cited by 2

P53, ARF et P16 : la ligne Maginot de la reprogrammation cellulaire

Grinand, M., & Vos, J. D. (2009) · médecine/sciences · doi:10.1051/medsci/20092510793 · Cited by 2

Engineering Cell Fate: The Roles of iPSC Transcription Factors, Chemicals, Barriers and Enhancing Factors in Reprogramming and TransdifferentiationPreprint

Ebrahimi, B. (2015) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/019455 · Cited by 2

miR-203 imposes an intrinsic barrier during cellular reprogramming by targeting NFATC2Preprint

Salazar‐Roa, M., Martı́nez-Martı́nez, S., Graña‐Castro, O., Álvarez‐Fernández, M., Trakala, M., Redondo, J. M., & Malumbres, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.02.131136 · Cited by 2

Amphiregulin mediates non-cell-autonomous effect of senescence on reprogrammingPreprint

von Joest, M., Chen, C., Douché, T., Chiche, A., Matondo, M., & Li, H. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.01.458621 · Cited by 2

iPSC culture

Daheron, L. M., & Chen, I. P.-F. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822277-5.00008-0 · Cited by 1

Molecular Diagnostics of Cancer [Working Title]

Piccaluga, P. P. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.111118 · Cited by 1

Phosphorylation and DNA damage resolution coordinate SOX2-mediated reprogramming in vivo

Zhong, X., Zou, Y., & Zhang, C. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519117123 · Cited by 1

The nuclear cap-binding complex safeguards stress-resistant protein synthesis and proliferation of stem cells

Oh, S., Chang, J., Jo, H., Yoon, J., Jang, S. K., Kim, Y. K., & Jang, J. (2026) · Science Advances · doi:10.1126/sciadv.aea6630 · Cited by 1

Loss of the tumor suppressor p53 generates a signaling gradient that drives epithelial clonal expansion

Gan, Q., Li, W., Lex, R. K., Ying, Z., & Beronja, S. (2026) · Science · doi:10.1126/science.aed3065 · Cited by 1

Transdifferentiation in the Nervous System

Liu, Y., & Rao, M. S. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3801-4_10 · Cited by 1

The regulation of signaling in hematopoietic stem cell maintenance

Lee, J. Y. (2012) · Cited by 1

Immortality improves cell reprogramming

Dolgin, E. (2009) · Nature · doi:10.1038/news.2009.809 · Cited by 1

p53 prevents pluripotency

Dolgin, E. (2009) · Nature reports. Stem cells · doi:10.1038/stemcells.2009.112 · Cited by 1

Engineering Transcription Factors in Breast Cancer Stem Cells

Blancafort, P., Juárez‐Moreno, K., Stolzenburg, S., & Sánchez‐Danés, A. (2011) · InTech eBooks · doi:10.5772/23788 · Cited by 1

Reprogramming of DPSC to Induced Pluripotent Stem Cells

Yıldırım, S. (2012) · SpringerBriefs in stem cells · doi:10.1007/978-1-4614-5687-2_7 · Cited by 1

Research on MicroRNAs in pluripotent stem cells

Wang, C., & Yang, S. (2013) · Zoological Research · doi:10.3724/sp.j.1141.2012.04416 · Cited by 1

Recent Improvements and Emerging Issues in iPSC Generation for the Modeling of Disease

Seki, T., Yuasa, S., & Fukuda, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-55966-5_1 · Cited by 1

Human iPS Cell Generation Methods for Clinical Usage

Seki, T. (2013) · CRC Press eBooks · doi:10.1201/b14990-3 · Cited by 1

Elucidation of PLK1 Linked Biomarkers in Oesophageal Cancer Cell Lines: A Step Towards Novel Signaling Pathways by p53 and PLK1-Linked Functions Crosstalk

Bibi, N., Hupp, T. R., Kamal, M. A., & Rashid, S. (2020) · Protein and Peptide Letters · doi:10.2174/0929866527999200901201837 · Cited by 1

Preventing phenotypic plasticity in cancer to mitigate therapy resistance

Coatham, M. L., Jewer, M., & Postovit, L.-M. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821310-0.00002-4 · Cited by 1

Self-renewal in induced pluripotent stem cells

Bárta, T., Bohačiaková, D., & Čajánek, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822231-7.00007-2 · Cited by 1

Induced Pluripotent Stem Cells

Takahashi, K., & Yamanaka, S. (2010) · Springer eBooks · doi:10.1007/978-90-481-9075-1_8 · Cited by 1

Induced Pluripotent Stem Cells

Okita, K., Takahashi, K., & Yamanaka, S. (2013) · Springer eBooks · doi:10.1007/978-94-007-5690-8_8 · Cited by 1

Induced Pluripotent Stem Cells

Osafune, K., & Yamanaka, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-380928-5.10013-2 · Cited by 1

A Novel Small Molecule Facilitates the Reprogramming of Human Somatic Cells into a Pluripotent State and Supports the Maintenance of an Undifferentiated State of Human Pluripotent Stem Cells

Lee, J., Xia, Y., Son, M., Jin, G., Seol, B., Kim, M., Son, M. J., Do, M., Lee, M., Kim, D., et al. (2012) · Angewandte Chemie · doi:10.1002/ange.201206691 · Cited by 1

What Is Regenerative Medicine?

Polak, J. M. (2010) · CRC Press eBooks · doi:10.1201/b10346-3 · Cited by 1

Genetic stability of hPSCs and considerations for cell therapy

Zanella, F., & Marcu, R. (2024) · Cell and Gene Therapy Insights · doi:10.18609/cgti.2024.023

Stem Cell Therapy in Parkinson’s Disease: Advances in Regenerative Medicine and Clinical Applications

Kumar, D. S., Ravi, R., Mahmood, A. A. R., Amirkhanyan, N., & Polevoy, G. G. (2025) · Global Journal of Medical Pharmaceutical and Biomedical Update · doi:10.25259/gjmpbu_42_2024 · Cited by 1

Reactivation of Multipotency in the Mammary Gland – a Ripple in the Pond and a Turn of the Tide

Hager, C., Jehanno, C., & Bentires‐Alj, M. (2025) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-025-09586-4 · Cited by 1

Self-renewal of Embryonic Stem Cells: Cell Cycle Regulation

Koledova, Z. S. (2012) · Springer eBooks · doi:10.1007/978-94-007-2993-3_2 · Cited by 1

Plasticity and Tumorigenicity

Campos‐Sánchez, E., Sánchez-Garcı́a, I., & Cobaleda, C. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/47289 · Cited by 1

The role of cell cycle in reprogramming toward induced pluripotent stem cells (iPSCs)

Neganova, I. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90059-1.00015-4 · Cited by 1

Induced Pluripotent Stem Cells

Yoshida, Y., & Yamanaka, S. (2013) · CRC Press eBooks · doi:10.1201/b14990-2 · Cited by 1

Therapeutic Possibilities of Induced Pluripotent Stem Cells

Ayetey, H. (2010) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-60761-959-8_8 · Cited by 1

Stem Cells and Parkinson's Disease

Lane, E. L., Sundberg, M., & Pruszak, J. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100019 · Cited by 1

Is the Perfect Mouse Cloning Experiment in Sight?

Boiani, M. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.088310 · Cited by 1

State of the stem cell

Baker, M. (2009) · Nature reports. Stem cells · doi:10.1038/stemcells.2009.132 · Cited by 1

A "Season of Light" in Stem Cell Research and Regenerative Medicine: Observations on Recent Developments

Womack, J. E. (2010) · ILAR Journal · doi:10.1093/ilar.51.1.85 · Cited by 1

Induced Pluripotent Stem Cells and the Promise of Proliferation

Williams, R. (2009) · Circulation Research · doi:10.1161/circresaha.109.211250 · Cited by 1

The Progress of Induced Pluripotent Stem Cells (iPSCs) for Research and Applications

Fu, Y., Zhou, X., Feng-qing, X. U., & Qian, Q. (2011) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2010.00333 · Cited by 1

Stem Cells in Cardiac Tissue Engineering

Christoforou, N., Lim, S. H. Y., & Leong, K. W. (2010) · WORLD SCIENTIFIC eBooks · doi:10.1142/9789814289399_0023 · Cited by 1

Micropatterned substrates to promote and dissect reprogramming of human somatic cellsPreprint

Carlson-Stevermer, J., Harkness, T., Prestil, R., Seymour, S. K., Knight, G. T., Ashton, R. S., & Saha, K. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/111369 · Cited by 1

Balancing dynamic tradeoffs drives cellular reprogrammingPreprint

Babos, K. N., Galloway, K. E., Kisler, K., Zitting, M., Li, Y., Quintino, B., Chow, R. H.-P., Zloković, B. V., & Ichida, J. K. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/393934 · Cited by 1

Non-cell-autonomous promotion of pluripotency induction mediated by YAPPreprint

Hartman, A. A., Hu, X., Chen, X., Eastman, A. E., Yang, C. L.-H., & Guo, S. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/481127 · Cited by 1

Molecular Mechanisms of Pluripotency

Yıldırım, S. (2012) · SpringerBriefs in stem cells · doi:10.1007/978-1-4614-2206-8_4

Induced Pluripotent Stem Cells

Takahashi, K., & Yamanaka, S. (2012) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.201100023 · Cited by 1

Gain-of-function oncogenic mutations in TP53 enhance defined factor-mediated cellular reprogrammingPreprint

Moon, J., Moon, J., Ishii, H., Dewi, D. L., Kano, Y., Yamamoto, K., Nishikawa, S., Fujiwara, Y., Doki, Y., & Mori, M. (2011) · Nature Precedings · doi:10.1038/npre.2011.5681 · Cited by 1

Somatic-to-primordial Germ Cell-Like Transformation is Critical in Tumour Initiation of Mouse Breast Tumour 4T1 CellsPreprint

Ma, Z., Zhang, F., Liu, A., Lin, H., & Liu, C. (2022) · Preprints.org · doi:10.20944/preprints202211.0080.v1 · Cited by 1

Secondary deficiency of neuraminidase 1 contributes to CNS pathology in neurological mucopolysaccharidoses via hypersialylation of brain glycoproteinsPreprint

Xu, T., Heon‐Roberts, R., Moore, T., Dubot, P., Pan, X., Guo, T., Cairo, C. W., Holley, R. J., Bigger, B., Durcan, T. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.26.587986 · Cited by 1

Gene Expression/Phenotypic Abnormalities in Placental Tissues of Sheep Clones: Insurmountable Block in Cloning Progress?

Loi, P., & Ptak, G. (2010) · Epigenetics and human health · doi:10.1007/978-3-642-14773-9_4

Control of Pluripotency and Reprogramming

Czeisler, C. M., Gygli, P. E., & Otero, J. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405544-5.00002-2

MicroRNAs in Cancer Stem Cells

Swarbrick, A. (2012) · Springer eBooks · doi:10.1007/978-94-007-4655-8_3

iPSC-Derived MSCs that Are Genetically Engineered for Systemic Bone Augmentation

Zhang, X. (2012) · doi:10.21236/ada568164

Role of P73 in endothelial cell differentation, vasculogenesis and angiogenesis

Alonso, R. F. (2013) · Buleria (Universidad de León) · doi:10.18002/10612/2882

Chemicals Facilitating Reprogramming

Shi, Z., Gonzãlez, F., & Huangfu, D. (2014) · Wiley eBooks · doi:10.1002/9781118695746.ch9

Inhibición de las rutas de ubiquitinación de proteínas dependientes de complejos Cullin-RING Ligasa en Sarcoma de Ewing: Validación preclínica y caracterización de mecanismos moleculares

Domínguez, D. J. G. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.122988

Manipulating Somatic Cells to Remove Barriers in Induced Pluripotent Stem Cell Reprogramming

Chung, J. E. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Wig-1: A p53 target that regulates the mRNA of p53 and Myc - and more?

Vilborg, A. (2010) · Figshare

Transcriptional profiling of pluripotent and multipotent stem cells to decipher pluripotency and lineage specification

Sharma, S. (2012) · University of Minnesota Digital Conservancy (University of Minnesota)

Regenerative Chimerism Bioengineered Through Stem Cell Reprogramming

Nelson, T. J., Martinez‐Fernandez, A., Yamada, S., & Terzic, A. (2010) · Springer eBooks · doi:10.1007/978-90-481-9075-1_19

New Techniques in the Generation of Induced Pluripotent Stem Cells

Raymond, C. B., Ellen, L., & Peter, J. (2011) · InTech eBooks · doi:10.5772/25208

Analysis of three dimensional culture mechanisms to induce de-differentiation and reprogramming in human multipotent stromal cells

Mason, R. R. (2014) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

TP53 mutations in myelodysplastic syndromes with deletion of 5q

Saft, L. (2013) · Figshare

Estudo das associações moleculares de ID4 em astrocitomas difusamente infiltrativos

Galatro, T. F. D. A. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2013.tde-25092013-161402

Pluripotency and Early Cell Fate Decisions are Orchestrated by microRNAs

Jung, M., & Schroeder, I. S. (2013) · Wiley eBooks · doi:10.1002/9781118695999.ch16

Switching Human Cell Fate: Reprogramming via pluripotency to adipogenesis

Ahfeldt, T. (2012)

Induced Pluripotent Stem Cells from Blood

Martin, U. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-471-1_7

Mechanisms of Stem Cell Regulation in Medulloblastoma

Yoo, R. (2013) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Molecular mechanisms involved in the induction of pluripotency

Acero, G. R. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-4322

Advances in Pluripotent and Adult Stem Cells for Eye Research

Peh, G. S. L., & Wong, R. C. B. (2014) · Stem cell biology and regenerative medicine · doi:10.1007/978-1-4939-0787-8_5

Transposable Elements and Human Pluripotency

Wang, J. (2015) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-13333

Bioengineered cardiogenicity through nuclear reprogramming: an IPS platform for heart regeneration

Martinez‐Fernandez, A. (2010) · doi:10.35376/10324/781

How to fight with senescent cells?

Chistiakov, D. A. (2011) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2010.00654.x

Analysis of gene expression in different cell types

Cai, Y., & Dai, X. (2013) · International Conference on Biomedical Engineering and Informatics (BMEI) · doi:10.1109/bmei.2013.6746933

The great iPS barrier

Wrighton, K. H. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2753

INVESTIGATING THE ROLES OF THE p63 ISOFORMS IN THE MICRORNA BIOGENESIS PATHWAY

Chakravarti, D. (2013) · Digital Commons-TMC (Texas Medical Center)

Differentiation of Human Atrial Myocytes From Endothelial Progenitor Cell-Derived Induced Pluripotent Stem Cells

Jambi, M. M., Ye, B., Gollob, M. H., & Davis, D. (2013) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2013.07.178

Research Highlights: Highlights from the Latest Articles in Regenerative Medicine

King, C. C., Sachlos, E., Kerstetter-Fogle, A. E., & Bollenbach, T. J. (2012) · Regenerative Medicine · doi:10.2217/rme.12.24

Evaluation of the TGF-ß Inhibitor RepSox on the Expression of Pluripotency Pathways in Murine and Bovine Cells

Larsen, D. M. (2021) · Digital Commons - USU (Utah State University) · doi:10.26076/8360-8f26

DERIVATION AND THERAPEUTIC POTENTIALS OF INDUCED PLURIPOTENT STEM CELLS

YANG, L., Lau, M.-S., & Ng, H. (2009) · Gene Therapy and Regulation · doi:10.1142/s1568558609000138

Eradication of therapy-resistant cancer cells in gastrointestinal organs

Nishikawa, S., Konno, M., Hamabe, A., Hasegawa, S., Ogawa, H., Kano, Y., Fukusumi, T., Ohta, K., NOGUCHI, Y., Ozaki, M., et al. (2012) · Molecular and Clinical Oncology · doi:10.3892/mco.2012.13

Induced pluripotent stem (iPS) cells offer a powerful new tool for the life sciences

Nakamura, Y. (2010) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0601002

CARDINAL REGENERATIVE FEATURES OF THE MRL MOUSE — AN UPDATE

Arthur, L. M., Sachadyn, P., Gourevitch, D., & Heber‐Katz, E. (2011) · Gene Therapy and Regulation · doi:10.1142/s1568558611000246

Review Induction of pluripotency in primordial germ cells

Kimura, T., & Nakano, T. (2011)

Targeting Mutant p53 for Improved Cancer Therapy

Shen, J., Bykov, V. J. N., & Wiman, K. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_14

The p53 Family and Stem Cell Biology

Agostini, M., Rufini, A., Bampton, E. T. W., Bernassola, F., Melino, G., & Knight, R. A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3676-8_4 · Cited by 1

Sox2 co-occupies distal enhancer elements with cell-type-specific POU factors to specify cell identity in embryonic stem cells and neural precursor cells

Lodato, M. A. (2012) · DSpace@MIT (Massachusetts Institute of Technology)

A regulatory network of Mdm2 and members of the Polycomb Group (PcG) family

Wienken, M. M. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5475

Battle for Pluripotency: Derivation of Induced Pluripotent Stem Cells

Mou, C., & Chen, L. (2011) · Recent Patents on Regenerative Medicine · doi:10.2174/2210296511101010123

p53: Guardian of reprogramming

Ménendez, S., Camus, S., & Belmonte, J. C. I. (2010) · Cell Cycle · doi:10.4161/cc.9.19.13301 · Cited by 88

The Journal of Experimental Medicine CORRESPONDENCE

Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O., Rotter, V., et al. (2013)

The p53–PUMA axis suppresses iPSC generation

Li, Y., Feng, H., Gu, H., Lewis, D. W., Yuan, Y., Zhang, L., Yu, H. M., Zhang, P., Cheng, H., Miao, W., et al. (2013) · Nature Communications · doi:10.1038/ncomms3174 · Cited by 64

Mutant p53 facilitates somatic cell reprogramming and augments the malignant potential of reprogrammed cells

Sarig, R., Rivlin, N., Brosh, R., Bornstein, C., Kamer, I., Ezra, O., Molchadsky, A., Goldfinger, N., Brenner, O. J., & Rotter, V. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20100797 · Cited by 162

Context‐Dependent Enhancement of Induced Pluripotent Stem Cell Reprogramming by Silencing Puma

Lake, B. B., Fink, J., Klemetsaune, L., Fu, X., Jeffers, J. R., Zambetti, G. P., & Xu, Y. (2012) · Stem Cells · doi:10.1002/stem.1054 · Cited by 30